Keith Bowering

5PUBLICATIONS
3CO-AUTHORS
Medical biochemistry - amino acids and metabolitesFood properties (incl. characteristics and health benefits)Phylogeny and comparative analysisPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 15, 2018
Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc Analysis.

Keith Bowering, Helena W Rodbard, David Russell-Jones

|Nov 23, 2018
Mealtime fast-acting insulin aspart versus insulin aspart for controlling postprandial hyperglycaemia in people with insulin-resistant Type 2 diabetes.

K Bowering, J Harvey, J W Kolaczynski

|May 27, 2018
The effect of basal-bolus therapy varies with baseline 1,5-anhydroglucitol level in people with Type 2 diabetes: a post hoc analysis.

S Heller, K Bowering, P Raskin

|May 10, 2017
Faster Aspart Versus Insulin Aspart as Part of a Basal-Bolus Regimen in Inadequately Controlled Type 2 Diabetes: The onset 2 Trial.

Keith Bowering, Christopher Case, John Harvey

Pageof 1

Frequent Collaborators

1 joint publications

S Heller

1 joint publications

Bruce W Bode

1 joint publications

David Russell-Jones